Tim Roberts, Chief Commercial Officer, sat down with Pharma’s Almanac’s Scientific Editor in Chief David Alvaro to discuss the advancements in oncology, the impact of COVID-19 on the industry, and why PCI is well-positioned to be a successful company
Balancing sufficient drug supply and excessive waste is not an exact science but a balance of risk and cost.
As the EU Clinical Trials Regulation (CTR) No 536/2014 go-live date approaches, this chat looks in more detail at some of the pros and cons of the Regulation.
Patient centric design and patient engagement, including graphic comprehension and elemental usability, coupled with end-to-end product protection require a robust design and development process.
VIDEO: Selecting the right partner to handle your package design can be crucial in successful commercialization. Learn how choosing PCI can be beneficial in streamlining the process, saving you time and money.
VIDEO: Identifying a partner with the relevant capabilities, expertise and experience to collaborate through this journey is a critical decision point for any company looking to outsource
When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?
Start your PCI experience today.Your bridge between life-changing therapies and patients.
